China Castson 81 Finance Company Limited Announces Substantial Rights Issue and Strategic Initiatives

Date: 13 March 2026

Key Highlights of the Rights Issue

• Rights Issue: China Castson 81 Finance Company Limited (Stock Code: 810) is launching a significant rights issue on the basis of five (5) Rights Shares for every two (2) existing Shares held as of the Record Date. The issue is non-fully underwritten and will proceed regardless of the subscription level, subject to certain conditions being met.
• Rights Issue Details:
  • Subscription Price: The price is set at a substantial discount to recent market prices, aiming to encourage participation. The specific discounts (26.62% to 31.08% versus various market references) are among the deepest compared to similar Hong Kong rights issues during the review period, making it potentially attractive to shareholders.
  • Size: Up to approximately HK\$49.24 million may be raised (assuming full subscription).
  • Offer Period: The latest time for acceptance is 4:00 p.m. on Friday, 27 March 2026.
  • Trading of Nil-Paid Rights: These will be available for trading, allowing shareholders to realize value even if they do not wish to subscribe.
• Underwriting and Major Shareholder Involvement:
  • The rights issue is partially underwritten by Goodchamp, a substantial shareholder controlled by Dr. Lam (Chairman and non-executive Director).
  • No underwriting commission is payable, which is rare and viewed as favorable for existing shareholders.
  • A Whitewash Waiver has been granted, allowing Goodchamp to increase its stake without triggering a mandatory general offer.
• Purpose and Use of Proceeds:
  • Approximately 70% (HK\$34.47 million) will be allocated to investments in listed and unlisted securities, with a focus on new energy, AI, and digital assets, including a prospective investment in a PRC-based new energy company (Guangzhou Heyue New Energy Technology Co., Ltd.).
  • The remaining 30% (HK\$14.77 million) is earmarked for general working capital—covering staff costs, administrative expenses, and professional fees.
• Shareholder Impact:
  • Dilution Risk: Shareholders who do not participate will see their holdings diluted. The theoretical dilution effect is estimated at 22.73%.
  • Trading Risk: Dealing in nil-paid Rights Shares before the rights issue becomes unconditional carries risk; the issue may not proceed if certain conditions are not met.

Strategic Rationale and Market Context

• The rights issue is positioned as critical for the company’s future, providing much-needed capital at a time when bank and cash balances were as low as HK\$304,000 as at 30 June 2025. The company’s net assets have also declined by nearly 12% in the last six months.
• The company cites a rebound in the Hong Kong and PRC capital markets, as well as government policy support for innovation and new energy, as reasons for optimism and the need to strengthen its balance sheet to seize emerging opportunities.
• The company is shifting its focus to investment in high-potential sectors such as new energy (including photovoltaics, hydrogen, energy storage), artificial intelligence, and digital assets. A memorandum of understanding has been signed for a possible HK\$5.5 million equity investment in a PRC new energy company.

Risks and Mechanisms for Shareholders

• Termination Clauses: The Underwriting Agreement can be terminated by Goodchamp under a wide range of adverse scenarios—including material adverse changes, regulatory actions, or significant market disruptions. If terminated, the rights issue will not proceed and the company will make an announcement.
• No Minimum Subscription: Other than shares committed to by Goodchamp, there is no minimum subscription level; the issue will simply be scaled down if under-subscribed.
• Odd Lot Arrangements: A securities firm will be appointed to help shareholders with odd lots post-issue, but matching is not guaranteed.
• Liquidity and Trading: The rights issue is structured to allow trading of entitlements, offering flexibility for shareholders to monetize or adjust their exposure.

Financial Performance and Outlook

• The company recorded a substantial loss of HK\$21.60 million for 2024, compared to HK\$6.31 million in 2023. However, losses narrowed significantly in the first half of 2025.
• The company has no outstanding debt as of 31 January 2026 and claims sufficient working capital post-issue for at least the next twelve months.
• The company’s investment strategy remains highly diversified, with a mandate to invest across Greater China, Asia-Pacific, and other markets, including unlisted companies with IPO potential.

Important Shareholder Considerations

• Price Sensitive / Share Price Drivers:
  • The deep discount of the rights issue, the potential for new strategic investments in high-growth sectors, and the involvement of a major shareholder in underwriting are all factors likely to impact the share price—both positively (if the strategy succeeds) or negatively (if dilution outweighs long-term benefits or if the issue is under-subscribed).
  • Uncertainty remains until the Rights Issue becomes unconditional, as termination clauses are broad and market conditions volatile.
• Recent Fundraising: The company has already raised HK\$3.61 million through a placing in October 2025, fully utilized for investments and working capital.
• No Dividend History: No dividends have been paid in recent years, and the company’s policy is to prioritize financial flexibility for investments over distributions.

Conclusion

The China Castson 81 Finance Rights Issue represents a pivotal moment for the company. If successful, it will provide essential capital for strategic investments in new energy, AI, and digital assets, positioning the company for potential growth in high-opportunity sectors. However, the sizeable dilution and reliance on a single major shareholder for underwriting, together with the company’s historical losses and low liquidity, mean that the outcome is uncertain and could be highly price sensitive.

Shareholders and investors are strongly advised to review the full prospectus, consider their own circumstances, and consult professional advisers before making any investment or trading decisions regarding the shares or the rights.

Disclaimer: The above article is for informational purposes only and does not constitute financial, legal, or tax advice. The information is based on the official prospectus and related disclosures as of the reporting date. Investors should conduct their own due diligence and consult with their professional advisers before making any investment decisions. The author and publisher accept no liability for any losses arising from reliance on this information.

View CH CASTSON 81 Historical chart here